Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
December-2022 Volume 24 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2022 Volume 24 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data1.xlsx
    • Supplementary_Data2.xlsx
Article Open Access

PROSER2 is a poor prognostic biomarker for patients with osteosarcoma and promotes proliferation, migration and invasion of osteosarcoma cells

  • Authors:
    • Zhengjiang Li
    • Yan Zhang
    • Yongkui Li
    • Shuxing Xing
    • Shunqiang Li
    • Jing Lyu
    • Zhaonan Ban
  • View Affiliations / Copyright

    Affiliations: Department of Orthopedics, Chengdu Fifth People's Hospital, Chengdu, Sichuan 611130, P.R. China
    Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 750
    |
    Published online on: November 8, 2022
       https://doi.org/10.3892/etm.2022.11686
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Proline‑ and serine‑rich 2 (PROSER2) is encoded by the 47th open reading frame on human chromosome 10. Bioinformatic analysis has shown PROSER2 was significantly correlated with prognostic outcome of osteosarcoma patients. Its role in the progression and metastasis of human osteosarcoma has not been elucidated until now. Bioinformatics analysis was performed on 101 patients with osteosarcoma from The Cancer Genome Atlas database. High levels of PROSER2 were associated with a poor prognosis in patients with osteosarcoma. PROSER2 expression was significantly upregulated in clinical specimens from patients with osteosarcoma and osteosarcoma cell lines. MTT assay was performed to test the cell viability and Transwell assay was used to test the migration and invasion of MG63 cells. PROSER2 knockdown inhibited the viability, migration and invasion of MG63 cells. Gene Set Enrichment Analysis and Gene Ontology/Kyoto Encyclopedia of Genes and Genomes analysis showed that the differentially expressed genes were primarily involved in ‘calcium signaling pathway’ and ‘Wnt signaling’ in patients with osteosarcoma and high PROSER2 expression. Western blotting analysis revealed that PROSER2 regulated migration and invasion of osteosarcoma via the Wnt/nuclear factor of activated T‑cells (NFAT)c1 signaling pathway. In conclusion, PROSER2 promoted the proliferation, migration and invasion of osteosarcoma cells via the Wnt/Ca2+/NFATc1 signaling pathway by increasing nuclear localization of NFATc1.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Yang G, Wu Y, Wan R, Sang H, Liu H and Huang W: The role of noncoding RNAs in the regulation, diagnosis, prognosis and treatment of osteosarcoma (review). Int J Oncol. 59(69)2021.PubMed/NCBI View Article : Google Scholar

2 

Gazouli I, Kyriazoglou A, Kotsantis I, Anastasiou M, Pantazopoulos A, Prevezanou M, Chatzidakis I, Kavourakis G, Economopoulou P, Kontogeorgakos V, et al: Systematic review of recurrent osteosarcoma systemic therapy. Cancers (Basel). 13(1757)2021.PubMed/NCBI View Article : Google Scholar

3 

Assi T, Kattan J, Nassereddine H, Rassy E, Briand S, Court C, Verret B, Le Cesne A and Mir O: Chemotherapy in the management of periosteal osteosarcoma: A narrative review. J Bone Oncol. 30(100389)2021.PubMed/NCBI View Article : Google Scholar

4 

Sugito W and Kamal AF: Clinical outcome following prolonged neoadjuvant chemotherapy and delayed surgery in osteosarcoma patients: An evidence-based clinical review. Acta Med Indones. 54:142–150. 2022.PubMed/NCBI

5 

Zhao X, Wu Q, Gong X, Liu J and Ma Y: Osteosarcoma: A review of current and future therapeutic approaches. Biomed Eng Online. 20(24)2021.PubMed/NCBI View Article : Google Scholar

6 

Wang T, Yu Q, Zhang W and Gao L: Comprehensive analysis of the PROSER2-AS1-related ceRNA network and immune cell infiltration in papillary thyroid carcinoma. Int J Gen Med. 15:1647–1663. 2022.PubMed/NCBI View Article : Google Scholar

7 

Hamada H, Okae H, Toh H, Chiba H, Hiura H, Shirane K, Sato T, Suyama M, Yaegashi N, Sasaki H and Arima T: Allele-specific methylome and transcriptome analysis reveals widespread imprinting in the human placenta. Am J Hum Genet. 99:1045–1058. 2016.PubMed/NCBI View Article : Google Scholar

8 

Parviainen R, Skarp S, Korhonen L, Serlo W, Mannikko M and Sinikumpu JJ: A single genetic locus associated with pediatric fractures: A genome-wide association study on 3,230 patients. Exp Ther Med. 20:1716–1724. 2020.PubMed/NCBI View Article : Google Scholar

9 

Sui Y, Ju C and Shao B: A lymph node metastasis-related protein-coding genes combining with long noncoding RNA signature for breast cancer survival prediction. J Cell Physiol. 234:20036–20045. 2019.PubMed/NCBI View Article : Google Scholar

10 

Chen J, Guo X, Zeng G, Liu J and Zhao B: Transcriptome analysis identifies novel prognostic genes in osteosarcoma. Comput Math Methods Med. 2020(8081973)2020.PubMed/NCBI View Article : Google Scholar

11 

Jiang X, Liu J, Guan Y, Zhao Z, Meng F and Wang X, Gao X, Zhou F, Chen Y and Wang X: The mechanism of the WNT5A and FZD4 receptor mediated WNT/β-catenin pathway in the degeneration of ALS spinal cord motor neurons. Biochem Biophys Res Commun. 609:23–30. 2022.PubMed/NCBI View Article : Google Scholar

12 

Choi JH, Kim YM, Park HJ, Nam MH and Seo YK: Extremely low-frequency electromagnetic fields increase cytokines in human hair follicles through Wnt/β-catenin signaling. Biomedicines. 10(924)2022.PubMed/NCBI View Article : Google Scholar

13 

Tong XK, Royea J and Hamel E: Simvastatin rescues memory and granule cell maturation through the Wnt/β-catenin signaling pathway in a mouse model of Alzheimer's disease. Cell Death Dis. 13(325)2022.PubMed/NCBI View Article : Google Scholar

14 

Daniels JR, Ma JZ, Cao Z, Beger RD, Sun J, Schnackenberg L, Pence L, Choudhury D, Palevsky PM, Portilla D and Yu LR: Discovery of novel proteomic biomarkers for the prediction of kidney recovery from dialysis-dependent AKI patients. Kidney360. 2:1716–1727. 2021.PubMed/NCBI View Article : Google Scholar

15 

Chu CY, Wang R and Liu XL: Roles of Wnt/β-catenin signaling pathway related microRNAs in esophageal cancer. World J Clin Cases. 10:2678–2686. 2022.PubMed/NCBI View Article : Google Scholar

16 

Chen Y, Chen Z, Tang Y and Xiao Q: The involvement of noncanonical Wnt signaling in cancers. Biomed Pharmacother. 133(110946)2021.PubMed/NCBI View Article : Google Scholar

17 

Vargas JY, Loria F, Wu YJ, Córdova G, Nonaka T, Bellow S, Syan S, Hasegawa M, van Woerden GM, Trollet C and Zurzolo C: The Wnt/Ca2+ pathway is involved in interneuronal communication mediated by tunneling nanotubes. EMBO J. 38(e101230)2019.PubMed/NCBI View Article : Google Scholar

18 

Zhang J, Chandrasekaran G, Li W, Kim DY, Jeong IY, Lee SH, Liang T, Bae JY, Choi I, Kang H, et al: Wnt-PLC-IP3-Connexin-Ca2+ axis maintains ependymal motile cilia in zebrafish spinal cord. Nat Commun. 11(1860)2020.PubMed/NCBI View Article : Google Scholar

19 

Farrera-Hernández A, Marín-Llera JC and Chimal-Monroy J: WNT5A-Ca2+-CaN-NFAT signalling plays a permissive role during cartilage differentiation in embryonic chick digit development. Dev Biol. 469:86–95. 2021.PubMed/NCBI View Article : Google Scholar

20 

Huybrechts Y, Mortier G, Boudin E and Van Hul W: WNT signaling and bone: Lessons from skeletal dysplasias and disorders. Front Endocrinol (Lausanne). 11(165)2020.PubMed/NCBI View Article : Google Scholar

21 

Yuan J, Yuan Z, Ye A, Wu T, Jia J, Guo J, Zhang J, Li T and Cheng X: Low GNG12 expression predicts adverse outcomes: A potential therapeutic target for osteosarcoma. Front Immunol. 12(758845)2021.PubMed/NCBI View Article : Google Scholar

22 

Wang J, Liu W, Li JC, Li M, Li B and Zhu R: Hepcidin downregulation correlates with disease aggressiveness and immune infiltration in liver cancers. Front Oncol. 11(714756)2021.PubMed/NCBI View Article : Google Scholar

23 

Du Y, Cao J, Jiang X, Cai X, Wang B, Wang Y, Wang X and Xue B: Comprehensive analysis of CXCL12 expression reveals the significance of inflammatory fibroblasts in bladder cancer carcinogenesis and progression. Cancer Cell Int. 21(613)2021.PubMed/NCBI View Article : Google Scholar

24 

Feng Z, Li L, Tu Y, Shu X, Zhang Y, Zeng Q, Luo L, Wu A, Chen W, Cao Y and Li Z: Identification of circular RNA-based immunomodulatory networks in colorectal cancer. Front Oncol. 11(779706)2021.PubMed/NCBI View Article : Google Scholar

25 

Love MI, Huber W and Anders S: Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15(550)2014.PubMed/NCBI View Article : Google Scholar

26 

Yang J, Zhang A, Luo H and Ma C: Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma. Sci Rep. 12(1279)2022.PubMed/NCBI View Article : Google Scholar

27 

Wan J, Liu Y, Long F, Tian J and Zhang C: circPVT1 promotes osteosarcoma glycolysis and metastasis by sponging miR-423-5p to activate Wnt5a/Ror2 signaling. Cancer Sci. 112:1707–1722. 2021.PubMed/NCBI View Article : Google Scholar

28 

Dai B, Shen Y, Yan T and Zhang A: Wnt5a/ROR1 activates DAAM1 and promotes the migration in osteosarcoma cells. Oncol Rep. 43:601–608. 2020.PubMed/NCBI View Article : Google Scholar

29 

Wang X, Zhao X, Yi Z, Ma B, Wang H, Pu Y, Wang J and Wang S: WNT5A promotes migration and invasion of human osteosarcoma cells via SRC/ERK/MMP-14 pathway. Cell Biol Int. 42:598–607. 2018.PubMed/NCBI View Article : Google Scholar

30 

Duan N, Zhang W, Song T, Li Z, Chen X and Ma W: A naturally derived small molecule PSM0537 targets the AF1Q-TCF4 interaction to suppress COX2 expression and inhibit cell proliferation and metastasis in osteosarcoma. Am J Cancer Res. 11:2637–2653. 2021.PubMed/NCBI

31 

Zhang X, Qu P, Zhao H, Zhao T and Cao N: COX2 promotes epithelialmesenchymal transition and migration in osteosarcoma MG63 cells via PI3K/AKT/NF-κB signaling. Mol Med Rep. 20:3811–3819. 2019.PubMed/NCBI View Article : Google Scholar

32 

Duan H, Ding X and Luo H: KISS-1, mediated by promoter methylation, suppresses esophageal squamous cell carcinoma metastasis via MMP2/9/MAPK axis. Dig Dis Sci. 67:4780–4796. 2022.PubMed/NCBI View Article : Google Scholar

33 

Liu J, Ding D, Liu F and Chen Y: Rhein inhibits the progression of chemoresistant lung cancer cell lines via the Stat3/Snail/MMP2/MMP9 pathway. Biomed Res Int. 2022(7184871)2022.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li Z, Zhang Y, Li Y, Xing S, Li S, Lyu J and Ban Z: PROSER2 is a poor prognostic biomarker for patients with osteosarcoma and promotes proliferation, migration and invasion of osteosarcoma cells. Exp Ther Med 24: 750, 2022.
APA
Li, Z., Zhang, Y., Li, Y., Xing, S., Li, S., Lyu, J., & Ban, Z. (2022). PROSER2 is a poor prognostic biomarker for patients with osteosarcoma and promotes proliferation, migration and invasion of osteosarcoma cells. Experimental and Therapeutic Medicine, 24, 750. https://doi.org/10.3892/etm.2022.11686
MLA
Li, Z., Zhang, Y., Li, Y., Xing, S., Li, S., Lyu, J., Ban, Z."PROSER2 is a poor prognostic biomarker for patients with osteosarcoma and promotes proliferation, migration and invasion of osteosarcoma cells". Experimental and Therapeutic Medicine 24.6 (2022): 750.
Chicago
Li, Z., Zhang, Y., Li, Y., Xing, S., Li, S., Lyu, J., Ban, Z."PROSER2 is a poor prognostic biomarker for patients with osteosarcoma and promotes proliferation, migration and invasion of osteosarcoma cells". Experimental and Therapeutic Medicine 24, no. 6 (2022): 750. https://doi.org/10.3892/etm.2022.11686
Copy and paste a formatted citation
x
Spandidos Publications style
Li Z, Zhang Y, Li Y, Xing S, Li S, Lyu J and Ban Z: PROSER2 is a poor prognostic biomarker for patients with osteosarcoma and promotes proliferation, migration and invasion of osteosarcoma cells. Exp Ther Med 24: 750, 2022.
APA
Li, Z., Zhang, Y., Li, Y., Xing, S., Li, S., Lyu, J., & Ban, Z. (2022). PROSER2 is a poor prognostic biomarker for patients with osteosarcoma and promotes proliferation, migration and invasion of osteosarcoma cells. Experimental and Therapeutic Medicine, 24, 750. https://doi.org/10.3892/etm.2022.11686
MLA
Li, Z., Zhang, Y., Li, Y., Xing, S., Li, S., Lyu, J., Ban, Z."PROSER2 is a poor prognostic biomarker for patients with osteosarcoma and promotes proliferation, migration and invasion of osteosarcoma cells". Experimental and Therapeutic Medicine 24.6 (2022): 750.
Chicago
Li, Z., Zhang, Y., Li, Y., Xing, S., Li, S., Lyu, J., Ban, Z."PROSER2 is a poor prognostic biomarker for patients with osteosarcoma and promotes proliferation, migration and invasion of osteosarcoma cells". Experimental and Therapeutic Medicine 24, no. 6 (2022): 750. https://doi.org/10.3892/etm.2022.11686
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team